Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 103

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 103
---
 filings under the QBCA in respect of the Arrangement; and (iv) any Authorizations which, if not obtained, or any other actions by or in respect                      
 of, or filings with, or notifications to, any Governmental Entity which, if not taken or made, would not be reasonably be expected to, individually or in the aggregate, prevent or materially impede the ability of the Purchaser to consummate the      
 Contemplated Transactions.                                                                                                                                                                                                                                |

| 4. | Residency |

The Purchaser is a non-residentof Canada for the purposes of the Tax Act.

| 5. | Regulatory Matters |

As calculated in accordance with the Competition Act(Canada) and the regulations thereto, the Purchaser and its affiliates (as that term is defined in the Competition Act(Canada)) have assets in Canada with a book value of less than $200 million and generate annual gross revenues from sales in, from or into Canada of less than $200 million.

| 6. | Litigation |

There are no material investigations, actions, suits or proceedings at Law or in equity or by or before any Governmental Entity now pending against or affecting the Purchaser (or its properties or assets) reasonably likely to prevent or materially delay consummation of the Contemplated Transactions.

| 7. | Compliance with Laws |

The Purchaser is in compliance with all applicable Laws, except for non-complianceswhich would not reasonably be expected to prevent or materially delay the completion of the Arrangement by the Purchaser.

| 8. | Sufficient Funds |

The Purchaser has (or has available to it), and will have as of the Effective Time sufficient cash available to pay all amounts to be paid by the Purchaser in connection with this agreement, including the Purchaser’s costs and expenses on the terms and conditions contained in this Agreement, and there is not, nor will there be, any restriction on the use of such cash or cash equivalents for such purpose. In no event shall the receipt or availability of any funds or financing by or to Purchaser or any of their respective affiliates or any other financing transaction be a condition to any of the obligations of Purchaser hereunder. C-2

SCHEDULE D REPRESENTATIONS AND WARRANTIES OF XRC

| 9. | Organization |

XRC is duly incorporated and is a company validly existing and in good standing under the laws of its jurisdiction of incorporation, with full power, authority and legal capacity to own or to complete the transactions to be completed